Mycobacterium Avium Complex Lung Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-11-12
Clinical Trial Update: ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension [Phase 3]
Phase 3 trial MNKD-101 (Clofazimine inhalation suspension) for MAC lung disease was terminated.